Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Daiichi Sankyo: Pipeline Products Performance Potential | Oct 2008 | £595 | 100% |
| World Pharmaceutical and Biopharmaceutical Market 2010-2015 (Pipeline Analysis of the Top 50 Companies) |
Jul 2010 | £2,845 | 80% |
| Atrial Fibrillation Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Dec 2010 | £1,265 | 78% |
| Anti-hypertension - Drug Pipeline Analysis and Market Forecasts to 2016 | Feb 2010 | £1,265 | 77% |
| Ono Pharmaceutical: Pipeline, Products, Performance, Potential | Jan 2012 | £595 | 77% |
| Kyowa Hakko: Pipeline, Products, Performance, Potential | Aug 2009 | £595 | 77% |
| Indian Pharmaceutical Market Outlook 2009-2024 | Nov 2009 | £1,499 | 71% |
| Anorexia Nervosa Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Dec 2011 | £2,215 | 69% |
| Takeda: Pipeline, Products, Performance, Potential | Nov 2009 | £595 | 66% |
| Eisai: Pipeline, Products, Performance, Potential | Nov 2009 | £595 | 65% |
| Rheumatoid Arthritis: World Drug Market 2011-2021 |
Sep 2011 | £1,699 | 64% |
| Tanabe Prospects to 2010 Pipeline, Products,Performance,Potential |
Sep 2007 | £595 | 64% |
| Non-Small Cell Lung Cancer (NSCLC) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Nov 2011 | £2,215 | 63% |
| Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 |
May 2011 | £1,499 | 63% |
| Prospects for Pharma Mergers, Acquisitions and Alliances 2010-2020 |
Jul 2010 | £1,499 | 63% |
| The World Antibacterial Treatments Market 2010-2024 |
Dec 2009 | £1,499 | 62% |
| Amgen: Pipeline • Products • Performance • Potential | Nov 2010 | £595 | 62% |
| The Pain Market Outlook to 2016 Healthcare |
Jul 2011 | £2,425 | 61% |
| Product Profiles: Osteoporosis Novel candidates offer the greatest potential |
Jun 2011 | £7,210 | 60% |
| Venous Thromboembolism (VTE) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Jan 2012 | £2,525 | 55% |
| Stakeholder Opinions: Respiratory viral infections Respiratory syncytial virus, parainfluenza virus and human metapneumovirus as promising new targets |
Apr 2010 | £2,405 | 54% |
| Osteoporosis & Bone Metabolism Disorders World Market 2010-2025 |
Apr 2010 | £1,499 | 53% |
| Multiple Sclerosis Treatment World Drug Market 2012-2022 |
Nov 2011 | £1,699 | 53% |
| Leading Anti-Cancer Drugs World Market Prospects 2011-2021 |
Feb 2011 | £1,499 | 53% |
| Asthma and COPD Therapies World Market 2011-2021 |
Aug 2011 | £1,499 | 52% |
| Therapeutic Monoclonal Antibodies World Market 2011-2021 |
Sep 2011 | £1,699 | 51% |
| Anti-Infective Drugs Markets | Oct 2010 | £8,980 | 50% |
| Global Pharmaceutical Biotech Market 2010-2025 Market growth, novel technologies and expansion into new therapeutic areas |
Dec 2009 | £1,499 | 50% |
| Antibacterial Drugs: World Market Prospects 2012-2022 |
Nov 2011 | £1,699 | 49% |
| World Multiple Myeloma Drug Treatment Market 2011-2021 |
Apr 2011 | £1,499 | 49% |
